European Org. for Research and Treatment of Cancer

European cancer organization offers guidelines for treating anemia

Published in Drug Law Weekly, December 7th, 2004

New European Organization for Research and Treatment of Cancer (EORTC) guidelines aim to assist physicians in managing anemia more effectively in their patients with cancer by providing advice on the appropriate use of erythropoietic proteins (EPO).

Such treatments can offer relief from numerous signs and symptoms of anemia, including debilitating fatigue, that place an added burden on the lives of patients with cancer.

These new evidence-based guidelines published in The European Journal of Cancer recognize that anemia, an abnormally low red blood cell count, is a frequent complication in patients with cancer. Approximately 60% of all...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Law Weekly

Source: Drug Law Weekly (2004-12-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry